Working… Menu

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients (PHYOX4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04555486
Recruitment Status : Completed
First Posted : September 18, 2020
Last Update Posted : September 10, 2021
Information provided by (Responsible Party):
Dicerna Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 7, 2021
Actual Study Completion Date : September 7, 2021